You are here

Article Text

Article menu
Download PDFPDF
Commentary
Abnormal liver blood tests among hospitalised patients with SARS-CoV2 (COVID-19)

https://doi.org/10.1136/flgastro-2020-101691

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Twitter @acv69cardenas

    • Contributors PR: interpreted the results, drafted and revised the manuscript. AC: interpreted the results, drafted, revised the manuscript and gave final approval.

    • Funding Andrés Cárdenas is funded by the Instituto de Salud Carlos III and Plan Estatal de Investigación Ciéntifica y Técnica y de Innovación-grant no PI19/00752 and has received funding for this work by 'Fundación Marta Balust'.

    • Competing interests AC is a consultant for Mallinckrodt Pharmaceuticals, Boston Scientific, Shionogi, has participated on Advisory Boards for Mallinckrodt Pharmaceuticals and has received grant support by Mallinckrodt and Boston Scientific.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    Linked Articles